Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DR26FY8ET
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,773
Award facts
- Contract value 100% obligated
- $17,773.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors, valued at $17,773.08 under a firm fixed-price arrangement. This non-set-aside delivery order was issued on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions, making this a specialized pharmaceutical procurement for military or veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated substantial capability in supplying specialty medications, biologics, and medical supplies across the Defense Health Agency's global healthcare operations. The non-set-aside status reflects the contractor's proven competitive positioning within the DLA's pharmaceutical supply chain for supporting military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FY8ET?
SPE2DR26FY8ET was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FY8ET worth?
The government has obligated $17,773 on SPE2DR26FY8ET.
Is contract SPE2DR26FY8ET an order under another contract?
Yes. SPE2DR26FY8ET is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8ET competed?
The extent of competition for SPE2DR26FY8ET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award